project id: TCGA-ESCA; case submitter id: TCGA-LN-A7HY; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.8; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.24; rna integrity number: 7.3; age at index: 50; days to birth: -18296; ethnicity: not hispanic or latino; gender: male; race: asian; vital status: Alive; year of birth: 1963; age at diagnosis: 18296; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage III; ajcc pathologic t: T3; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 366.0; icd 10 code: C15.3; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper third of esophagus; synchronous malignancy: No; tissue or organ of origin: Upper third of esophagus; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: yes; alcohol history: Yes; is ffpe: false; composition: Not Reported; days to collection: 162; days to sample procurement: 0; initial weight: 360.0; portion submitter id: TCGA-LN-A7HY-01A-12; percent lymphocyte infiltration: 15.0; percent monocyte infiltration: 0.0; percent necrosis: 3.0; percent neutrophil infiltration: 0.0; percent normal cells: 4.0; percent stromal cells: 21.0; percent tumor cells: 72.0; percent tumor nuclei: 84.0;